Press Release

View printer-friendly version << Back
Columbia Laboratories to Discuss Third Quarter 2014 Financial Results on October 28th Conference Call

BOSTON, Oct. 14, 2014 /PRNewswire/ -- The management team at Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on October 28th, 2014, to discuss financial results for the third quarter ended September 30, 2014. The call details are as follows:


Tuesday, October 28, 2014


8:30 AM EDT

Dial-in numbers:

Toll free: (866) 374-4635 (U.S.), (855) 669-9657 (Canada) or,

International: (412) 902-4218

Webcast (live & archive):, under 'Investor' or click here

The teleconference replay will be available approximately one hour after completion through Wednesday, November 5, 2014, at (877) 344-7529 (U.S.), (855) 669-9658 (Canada) or (412) 317-0088 (International). The conference ID for the replay is 10054330. The archived webcast will be available for one year via the aforementioned URLs.

About Columbia Laboratories

Columbia Laboratories, Inc. is a pharmaceutical development company providing formulation development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry. The Company is also leveraging a successful heritage in developing women's health products and is advancing a proprietary product pipeline. Its most successful product to date, CRINONE® 8% (progesterone gel), is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 additional countries worldwide. For more information, please visit

CRINONE® is a registered trademark of Actavis, Inc. in the U.S.

MBS Value Partners
Katja Buhrer
+212 661 7004

SOURCE Columbia Laboratories, Inc.